New 5-Shot radiation could spare healthy breast tissue in early cancer
NCT ID NCT03581136
First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 21 times
Summary
This study tests a new way to give radiation to early-stage breast cancer using a device called the GammaPod. Instead of many sessions, patients get just 5 precise doses aimed at the tumor while sparing healthy tissue. The goal is to see if this approach keeps the cancer from coming back and gives better cosmetic results. About 74 women with small, early breast cancers are taking part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UT Southwestern Medical Centre
Dallas, Texas, 75390, United States
-
University of Maryland Medical Center
Baltimore, Maryland, 21201, United States
Conditions
Explore the condition pages connected to this study.